Literature DB >> 31696658

Meta-Analyses Support Previous and Novel Autism Candidate Genes: Outcomes of an Unexplored Brazilian Cohort.

Eduarda Morgana da Silva Montenegro1, Claudia Samogy Costa1, Gabriele Campos1, Marília Scliar1, Tatiana Ferreira de Almeida1, Elaine Cristina Zachi1, Isabela Maya Wahys Silva1, Ada J S Chan2,3, Mehdi Zarrei3, Naila C V Lourenço1, Guilherme Lopes Yamamoto1, Stephen Scherer2,3, Maria Rita Passos-Bueno1.   

Abstract

Large genomic databases of neurodevelopmental disorders (NDD) are helpful resources of genomic variations in complex and heterogeneous conditions, as Autism Spectrum Disorder (ASD). We evaluated the role of rare copy number variations (CNVs) and exonic de novo variants, in a molecularly unexplored Brazilian cohort of 30 ASD trios (n = 90), by performing a meta-analysis of our findings in more than 20,000 patients from NDD cohorts. We identified three pathogenic CNVs: two duplications on 1q21 and 17p13, and one deletion on 4q35. CNVs meta-analysis (n = 8,688 cases and n = 3,591 controls) confirmed 1q21 relevance by identifying duplications in other 16 ASD patients. Exome analysis led the identification of seven de novo variants in ASD genes (SFARI list): three loss-of-function pathogenic variants in CUL3, CACNA1H, and SHANK3; one missense pathogenic variant in KCNB1; and three deleterious missense variants in ATP10A, ANKS1B, and DOCK1. From the remaining 12 de novo variants in non-previous ASD genes, we prioritized PRPF8 and RBM14. Meta-analysis (n = 13,754 probands; n = 2,299 controls) identified six and two additional patients with validated de novo variants in PRPF8 and RBM14, respectively. By comparing the de novo variants with a previously established mutational rate model, PRPF8 showed nominal significance before multiple test correction (P = 0.039, P-value adjusted = 0.079, binomial test), suggesting its relevance to ASD. Approximately 60% of our patients presented comorbidities, and the diagnostic yield was estimated in 23% (7/30: three pathogenic CNVs and four pathogenic de novo variants). Our uncharacterized Brazilian cohort with tetra-hybrid ethnic composition was a valuable resource to validate and identify possible novel candidate loci. Autism Res 2020, 13: 199-206.
© 2019 International Society for Autism Research, Wiley Periodicals, Inc. LAY SUMMARY: We believed that to study an unexplored autistic population, such as the Brazilian, could help to find novel genes for autism. In order to test this idea, with our limited budget, we compared candidate genes obtained from genomic analyses of 30 children and their parents, with those of more than 20,000 individuals from international studies. Happily, we identified a genetic cause in 23% of our patients and suggest a possible novel candidate gene for autism (PRPF8). © 2019 International Society for Autism Research, Wiley Periodicals, Inc.

Entities:  

Keywords:  zzm321990PRPF8; zzm321990RMB14; DDD; MSSNG; SSC

Year:  2019        PMID: 31696658     DOI: 10.1002/aur.2238

Source DB:  PubMed          Journal:  Autism Res        ISSN: 1939-3806            Impact factor:   5.216


  8 in total

1.  Rare CACNA1H and RELN variants interact through mTORC1 pathway in oligogenic autism spectrum disorder.

Authors:  André Luíz Teles E Silva; Talita Glaser; Karina Griesi-Oliveira; Juliana Corrêa-Velloso; Jaqueline Yu Ting Wang; Gabriele da Silva Campos; Henning Ulrich; Andrea Balan; Mehdi Zarrei; Edward J Higginbotham; Stephen W Scherer; Maria Rita Passos-Bueno; Andrea Laurato Sertié
Journal:  Transl Psychiatry       Date:  2022-06-06       Impact factor: 7.989

2.  Two Genetic Mechanisms in Two Siblings with Intellectual Disability, Autism Spectrum Disorder, and Psychosis.

Authors:  Yu-Shu Huang; Ting-Hsuan Fang; Belle Kung; Chia-Hsiang Chen
Journal:  J Pers Med       Date:  2022-06-20

3.  Cul3 regulates cytoskeleton protein homeostasis and cell migration during a critical window of brain development.

Authors:  Jasmin Morandell; Lena A Schwarz; Bernadette Basilico; Saren Tasciyan; Georgi Dimchev; Armel Nicolas; Christoph Sommer; Caroline Kreuzinger; Christoph P Dotter; Lisa S Knaus; Zoe Dobler; Emanuele Cacci; Florian K M Schur; Johann G Danzl; Gaia Novarino
Journal:  Nat Commun       Date:  2021-05-24       Impact factor: 14.919

4.  Exome Evaluation of Autism-Associated Genes in Amazon American Populations.

Authors:  Giovana E da Costa; Giordane L Fernandes; Juliana C G Rodrigues; Diana F da V B Leal; Lucas F Pastana; Esdras E B Pereira; Paulo P Assumpção; Rommel M R Burbano; Sidney E B Dos Santos; João F Guerreiro; Marianne R Fernandes; Ney P C Dos Santos
Journal:  Genes (Basel)       Date:  2022-02-18       Impact factor: 4.096

5.  Analysis of recent shared ancestry in a familial cohort identifies coding and noncoding autism spectrum disorder variants.

Authors:  Islam Oguz Tuncay; Nancy L Parmalee; Raida Khalil; Kiran Kaur; Ashwani Kumar; Mohamed Jimale; Jennifer L Howe; Kimberly Goodspeed; Patricia Evans; Loai Alzghoul; Chao Xing; Stephen W Scherer; Maria H Chahrour
Journal:  NPJ Genom Med       Date:  2022-02-21       Impact factor: 8.617

6.  Contribution of CACNA1H Variants in Autism Spectrum Disorder Susceptibility.

Authors:  Marta Viggiano; Tiziano D'Andrea; Cinzia Cameli; Annio Posar; Paola Visconti; Maria Cristina Scaduto; Roberta Colucci; Magali J Rochat; Fabiola Ceroni; Giorgio Milazzo; Sergio Fucile; Elena Maestrini; Elena Bacchelli
Journal:  Front Psychiatry       Date:  2022-03-08       Impact factor: 4.157

7.  Interleukin-17a Induces Neuronal Differentiation of Induced-Pluripotent Stem Cell-Derived Neural Progenitors From Autistic and Control Subjects.

Authors:  Ana Karolyne Santos Gomes; Rafaelly Mayara Dantas; Bruno Yukio Yokota; André Luiz Teles E Silva; Karina Griesi-Oliveira; Maria Rita Passos-Bueno; Andréa Laurato Sertié
Journal:  Front Neurosci       Date:  2022-03-14       Impact factor: 4.677

Review 8.  Profiles of urine and blood metabolomics in autism spectrum disorders.

Authors:  Narueporn Likhitweerawong; Chanisa Thonusin; Nonglak Boonchooduang; Orawan Louthrenoo; Intawat Nookaew; Nipon Chattipakorn; Siriporn C Chattipakorn
Journal:  Metab Brain Dis       Date:  2021-08-02       Impact factor: 3.655

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.